EUTHYMICS BIOSCIENCE
Euthymics Bioscience, Inc. is a neuroscience-focused clinical-stage company developing next-generation treatments for depression. Euthymics’ initial focus is on patients who do not respond adequately to SSRIs. EB-1010 for depression is expected to improve efficacy and reduce the leading side effects associated with poor adherence to standard antidepressants including weight gain, sexual dysfunction and cognitive impairment. Euthymics is a private Delaware corporation with headquarters... in Cambridge, Massachusetts. Euthymics is developing products for central nervous system disorders of significant unmet medical need, including major depressive disorder (MDD) and, under a collaboration with the government, alcohol use disorder (AUD). According to the National Institutes of Health, MDD affects over 15 million American adults. According to the National Institute of Alcohol Abuse and Alcoholism (NIAAA), approximately 18 million Americans have alcohol use disorder (either alcohol dependence or alcohol abuse).
EUTHYMICS BIOSCIENCE
Social Links:
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2009-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.euthymics.com
Total Employee:
11+
Status:
Active
Contact:
617-758-0300
Email Addresses:
[email protected]
Total Funding:
38.5 M USD
Technology used in webpage:
Facebook Sharer Pinterest New Relic WhatsApp OVH Facebook Like Button Plesk Citrix NetScaler ClouDNS Kk Star Ratings
Current Advisors List
Current Employees Featured
Founder
Investors List
GBS Ventures
GBS Ventures investment in Series A - Euthymics Bioscience
H&Q Venture Capital
H&Q Venture Capital investment in Series A - Euthymics Bioscience
Novartis Venture Fund
Novartis Venture Fund investment in Series A - Euthymics Bioscience
Venture Investors
Venture Investors investment in Series A - Euthymics Bioscience
Hambrecht & Quist Capital Management
Hambrecht & Quist Capital Management investment in Series A - Euthymics Bioscience
GBS Ventures
GBS Ventures investment in Series A - Euthymics Bioscience
Novartis Venture Fund
Novartis Venture Fund investment in Series A - Euthymics Bioscience
Official Site Inspections
http://www.euthymics.com
- Host name: 104.21.16.1
- IP address: 104.21.16.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Euthymics Bioscience"
Euthymics Bioscience - Crunchbase Company Profile
Euthymics Bioscience, a neuroscience-focused biopharmaceutical company, develops medicines for central nervous system disorders. See details»
Organization | Euthymics BioScience, Inc.
Euthymics BioScience, Inc. Report issue For profit Phase 3 Founded: Cambridge MA United States (2009) Status: Acquired by Ethismos (2017) Organization Overview First Clinical Trial … See details»
Euthymics Bioscience, Inc.: Contact Details and Business Profile
Euthymics Bioscience, Inc. is a Biotechnology, Neuropsychiatric drug development, and Pharmaceuticals company located in Cambridge, Massachusetts with 1 employees. Find top … See details»
Euthymics Bioscience 2025 Company Profile: Valuation, …
Information on acquisition, funding, investors, and executives for Euthymics Bioscience. Use the PitchBook Platform to explore the full profile. See details»
Euthymics Bioscience - VentureRadar
Euthymics’ management team is a group of experienced drug developers with a track record of success in neuroscience product development. We are dedicated to providing better … See details»
Euthymics Bioscience, Inc. Company Profile | Cambridge, MA ...
Find company research, competitor information, contact details & financial data for Euthymics Bioscience, Inc. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet. See details»
EIN 22-3374365 - Euthymics Bioscience, Inc., Braintree, …
The Employer Identification Number (EIN) for Euthymics Bioscience, Inc. is 22-3374365. EIN numbers are also referred to as FEIN or FTIN. Find EIN, Contact Details for Euthymics … See details»
Euthymics Bioscience Inc - Company Profile and News
Company profile page for Euthymics Bioscience Inc including stock price, company news, executives, board members, and contact information See details»
Euthymics - 2025 Company Profile, Funding & Competitors - Tracxn
Apr 28, 2025 Euthymics is a deadpooled company based in Cambridge (United States), founded in 2009 by Anthony McKinney. It operates as a Medicine for alcohol use disorder (AUD) and … See details»
Euthymics Bioscience - Products, Competitors, Financials, …
About Euthymics Bioscience Euthymics Bioscience is developing a novel medicine for alcohol use disorder (AUD) and smoking cessation. The name Euthymics is related to the word "euthymia" … See details»
Euthymics Bioscience | VentureRadar
Euthymics is a neuroscience-focused, clinical-stage biopharmaceutical company. Euthymics is developing a novel medicine for major depressive disorder. Euthymics’ management team is a … See details»
Euthymics Bioscience - Contacts, Employees, Board Members, …
Euthymics Bioscience, a neuroscience-focused biopharmaceutical company, develops medicines for central nervous system disorders. See details»
Walter Piskorski - COO @ Euthymics Bioscience - Crunchbase
Walter Piskorski is the COO at Euthymics Bioscience. Additionally, Walter Piskorski has had 4 past jobs including COO at Neurovance. See details»
ETHISMOS RESEARCH INC. CLOSES DEAL — Ethismos Research, Inc
Nov 1, 2017 CAMBRIDGE, Mass.-- (BUSINESS WIRE)--Ethismos Research Inc. a clinical-stage pharmaceutical company focused on addiction and depression founded by Anthony McKinney, … See details»
Euthymics Bioscience - Funding, Financials, Valuation & Investors
Euthymics Bioscience, a neuroscience-focused biopharmaceutical company, develops medicines for central nervous system disorders. See details»
The Euthymics - Facebook
The Euthymics. 117 likes. The Euthymics are a small band of geographically diverse general practitioners who treat the ill by See details»
What Is Euthymia In Psychology And How To Identify It
What is Euthymia? The term euthymia comes from the Greek words eu (meaning “good” or “well”) and thymos (meaning “soul” or “emotion”), translating roughly to “a good mood” or “mental … See details»
Euthymics Bioscience - Crunchbase
Euthymics Bioscience, a neuroscience-focused biopharmaceutical company, develops medicines for central nervous system disorders. See details»
Euthymics Bioscience - Updates, News, Events, Signals & Triggers
Euthymics Bioscience, a neuroscience-focused biopharmaceutical company, develops medicines for central nervous system disorders. See details»
Euthymics Bioscience - Tech Stack, Apps, Patents & Trademarks
Euthymics Bioscience, a neuroscience-focused biopharmaceutical company, develops medicines for central nervous system disorders. See details»